Power, Politics and the Future of UK Medical Cannabis

EP2 - Robert Jappie, partner at Fieldfisher LLP and Tim Kirby, CEO at Releaf unpack the challenges and opportunities shaping the UK’s medical cannabis landscape, from the slow-moving regulatory environment to the urgent need for patient-focused innovation.Key topics include:- Why the UK's medical cannabis framework has barely shifted since legalisation in 2018- The bottlenecks across cultivation, distribution and clinical access- How education and reduced stigma are slowly driving patient growth- What the UK can learn from Germany’s market- The future: cannabis oils, vape cartridges and engaging the 'cannabis-naive"Spotify Video Chapters:00:00 Beyond The Script with Robert Jappie00:46 Understanding the Regulatory Landscape02:11 The Four Stages of the Supply Chain03:37 The 2018 Legislation and Its Impact05:22 Challenges and Opportunities in the Industry06:29 Robert's Background and Expertise08:14 THC Regulations and Industry Struggles10:31 The Role of Regulators and Compliance17:28 Supply Chain Improvements and Future Outlook20:02 Addressing the Cannabis Market20:22 Releaf's Approach to Medical Cannabis21:47 Challenges in the UK Cannabis Market23:24 Building Trust and Patient Advocacy25:10 Innovative Delivery Methods29:51 The Dispensary Model and Legalisation33:39 Lessons from the German Market36:51 Future Prospects and Legal ChallengesFollow us:InstagramTikTokTwitterLinkedinreleaf.co.uk